"L’Institut Català de Retina és un centre oftalmològic, mèdic i quirúrgic amb més de 30 anys d’experiència. El seu objectiu és la prevenció, el diagnòstic, el tractament i el control de les malalties de l’ull, del sistema visual i dels annexos oculars. Als nostres centres oferim una atenció de qualitat i personalitzada i proporcionem un servei integral que va des de consultes, fins a intervencions quirúrgiques, passant per tractaments de totes les especialitats oftalmològiques. A més, disposem d'un servei d’urgències oftalmològiques, que està obert 24 h tots els dies de l'any."

During the past decade, Institut Catala de Retina conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Catala de Retina" #1 sponsor was "Institut Catala de Retina" with 2 trials, followed by "Sylentis, S.A." with 2 trials sponsored, "Allergan" with 1 trials sponsored, "GenSight Biologics" with 1 trials sponsored and "IVERIC bio, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Catala de Retina" #1 collaborator was "Clinica Universidad de Navarra, Universidad de Navarra" with 1 trials as a collaborator, "Gregorio Marañón Hospital" with 1 trials as a collaborator, "Hospital San Eloy" with 1 trials as a collaborator, "Hospital Universitario Ramon y Cajal" with 1 trials as a collaborator and "Hospital Vall d'Hebron" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Institut Catala de Retina" are "Ocular Hypertension" (3 trials), "Open Angle Glaucoma" (2 trials), "Dry Age-related Macular Degeneration" (1 trials), "Dry Eye Disease" (1 trials) and "Geographic Atrophy" (1 trials). Many other conditions were trialed in "Institut Catala de Retina" in a lesser frequency.

Most popular intervention types in "Institut Catala de Retina" are "Drug" (5 trials), "Device" (2 trials), "Other" (2 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Active Comparator: Timolol 0.5%" (1 trials), "Bimatoprost SR" (1 trials), "Cataract extraction" (1 trials), "Citicoline" (1 trials) and "Citicoline and Docosahexaenoic Acid (DHA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Catala de Retina" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Institut Catala de Retina". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Institut Catala de Retina, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Catala de Retina, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".